Library

All
,

A New Paradigm in mRNA Bioprocessing. How Ntensify™ Reshapes Affordability and Reduces Time-to-Market

Learn More »

, ,

Quantoom Biosciences Prepares for the Implementation of the Ntensify™ Midi System by Afrigen Biologics’ in their GMP Facility, Paving the Way for African-Owned mRNA Vaccine Production

Learn More »

, ,

Quantoom Biosciences Collaborates with Stevanato Group to Elevate mRNA production with Nfinity™ Platform

Learn More »

,

mRNA Production Reinvented

Learn More »

, ,

Quantoom Biosciences expands its offerings with Nplify, a high-quality linear DNA service for mRNA synthesis

Learn More »

, ,

Quantoom expands U.S. Market Reach with Key Appointments

Learn More »

, ,

Quantoom Biosciences installs the first Ntensify™ system for mRNA manufacturing at Afrigen Biologics in Cape Town

Learn More »

, ,

ImmuneWatch, Quantoom Biosciences and UAntwerp join forces to explore new in vitro and in silico assays that predict T cell responses in vaccines

Learn More »

, ,

Quantoom Biosciences is growing in France with brand-new facilities for its DNA and enzymes activity located in Evry

Learn More »

,

Rabies mRNA Vaccine

Learn More »

,

Poster mRNA Health Conference

Learn More »

,

Fact Sheet Ntensify mini

Learn More »

,

Fact Sheet Ntensify midi

Learn More »

,

New agreement paves way for development of first African-owned COVID-19 vaccine

Learn More »

,

Univercells acquires SynHelix, entering into synthetic biology and the race to next-generation DNA synthesis

Learn More »

,

Quantoom Biosciences granted $13.9 Million (€12.4 million), to support the development of its novel mRNA manufacturing platform for vaccines and therapeutics

Learn More »

,

eTheRNA immunotherapies and Quantoom Biosciences Announce a Strategic Collaboration for the Development of a Novel RNA Production System

Learn More »

,

Introducing Quantoom Biosciences, a Univercells company, with the mission to improve access to essential medicines and autonomy in bioproduction through innovation

Learn More »

Press Releases

All,  Press Release,  Uncategorized

Quantoom Biosciences Prepares for the Implementation of the Ntensify™ Midi System by Afrigen Biologics’ in their GMP Facility, Paving the Way for African-Owned mRNA Vaccine Production

Learn more →

All,  Press Release,  Uncategorized

Quantoom Biosciences Collaborates with Stevanato Group to Elevate mRNA production with Nfinity™ Platform

Learn more →

All,  Press Release,  Uncategorized

Quantoom Biosciences expands its offerings with Nplify, a high-quality linear DNA service for mRNA synthesis

Learn more →

All,  Press Release,  Uncategorized

Quantoom expands U.S. Market Reach with Key Appointments

Learn more →

All,  Press Release,  Uncategorized

Quantoom Biosciences installs the first Ntensify™ system for mRNA manufacturing at Afrigen Biologics in Cape Town

Learn more →

All,  Press Release,  Uncategorized

ImmuneWatch, Quantoom Biosciences and UAntwerp join forces to explore new in vitro and in silico assays that predict T cell responses in vaccines

Learn more →
Fact Sheets
,

Fact Sheet Ntensify mini

Ntensify mini, for Drug Discovery and Pre-Clinical Phase.

Learn More »

,

Fact Sheet Ntensify midi

Ntensify midi, for Clinical Phases & Commercial Production

Learn More »

Posters
,

Poster mRNA Health Conference

Learn More »

White Papers
,

A New Paradigm in mRNA Bioprocessing. How Ntensify™ Reshapes Affordability and Reduces Time-to-Market

Rabies mRNA Vaccine Download the case study as a pdf:   Contact Us

Learn More »

,

Rabies mRNA Vaccine

Rabies mRNA Vaccine Download the case study as a pdf:   Contact Us

Learn More »

Corporate Presentations
,

mRNA Production Reinvented

mRNA Production Reinvented Download the Corporate presentation as a pdf:   Contact Us

Learn More »

Videos
black-up-orange